电子邮件 | liu***@***.com | 获取Email |
---|
电子邮件 | liu***@***.com | 获取Email |
---|
Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a global pharmaceutical company engaged in the development and commercialization of innovative and high-quality drugs, focusing on the research and development of new drugs in the fields of anti-tumor, surgical drugs, autoimmune diseases, metabolic diseases and cardiovascular diseases. Innovation is the core development strategy. Hengrui has 12 innovative products and 1 cooperative innovative product marketed, more than 60 innovative candidates in the R&D stage, and more than 260 trials under clinical development around the world. Hengrui ranked 24th among the top 1,000 global pharma companies announced by the Torreya in 2021. We have been on the Pharma Exec's annual listing of the top global pharmaceutical companies for the fourth consecutive year, rising from 47th in 2019 to 32nd in 2022.
公司 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
---|---|
职位 | Group Leader of Analytical R&D (Drug Product) , at International Generics R&D Department of Hengrui |
地点 | China |
http://www.linkedin.com/in/liu-qiang-qiang-37199331 | |
部门 | master_engineering_technical |
头衔 | Group Leader of Analytical R&D (Drug Product) , at International Generics R&D Department of Hengrui |
Liu Qiang 在 Jiangsu Hengrui Pharmaceuticals Co., Ltd. 担任 Group Leader of Analytical R&D (Drug Product) , at International Generics R&D Department of Hengrui
Liu Qiang 在 Jiangsu Hengrui Pharmaceuticals Co., Ltd. 的职位是 Group Leader of Analytical R&D (Drug Product) , at International Generics R&D Department of Hengrui
Liu Qiang 的电子邮件地址是 liu***@***.com
Liu Qiang 的电话号码是 -
Liu Qiang 的公司电话号码是 +868****
Liu Qiang 在 pharmaceuticals 工作。
Liu Qiang 的一些同事包括Kaimeng Zhou、Lin Luo、Martin Ye、Pranima MaharjanXiaotong Li、。
Liu Qiang联系方式: 电子邮件地址:liu***@***.com 电话号码:-
Liu Qiang 的个人领英是:http://www.linkedin.com/in/liu-qiang-qiang-37199331
Liu Qiang 的办公地点:no.7 kunlunshan rd, lianyungang, china
Top-ranked on G2 Crowd
全球B2B企业库 海关贸易数据 展会采购数据
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd